Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Allergy and Asthma Proceedings|May 10, 2011
Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007Marya D Zilberberg, Brian H Nathanson, Thomas Jacobsen, et al.
Future Microbiology|September 22, 2020
Omadacycline: a therapeutic review of use in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionsTeena Chopra, Avnish Sandhu, Nicolette Theriault, et al.
Patient Preference and Adherence|September 5, 2023
Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile InfectionPaul Feuerstadt, Caterina Oneto, Glenn Tillotson, et al.
Open Forum Infectious Diseases|May 29, 2020
The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database StudyBin Cai, Glenn Tillotson, Darrin Benjumea, et al.
Allergy and Asthma Proceedings|December 27, 2011
Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006-2007Marya D Zilberberg, Brian H Nathanson, Thomas Jacobsen, et al.
Advances in Therapy|May 18, 2019
Efficacy and Safety of Meropenem-Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc AnalysisMatteo Bassetti, Daniele Roberto Giacobbe, Niki Patel, et al.
Open Forum Infectious Diseases|March 21, 2020
Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database StudyGlenn Tillotson, Thomas Lodise, Peter Classi, et al.
Therapeutic Advances in Infectious Disease|December 6, 2021
Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigationSimon Portsmouth, Roger Echols, Kiichiro Toyoizumi, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2007
Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind studyThomas M File, Lionel A Mandell, Glenn Tillotson, et al.
BMC Infectious Diseases|April 17, 2015
A randomised phase 1 study to investigate safety, pharmacokinetics and impact on gut microbiota following single and multiple oral doses in healthy male subjects of SMT19969, a novel agent for Clostridium difficile infectionsRichard Vickers, Neil Robinson, Emma Best, et al.
Pageof 5